November 11, 2020
FDA Grants an EUA for Bamlanivimab to Treat COVID-19 Patients Who Meet Certain Criteria
The U.S. Food and Drug Administration has granted Eli Lilly and Company an emergency use authorization for bamlanivimab to treat mild-to-moderate COVID-19 in adult and pediatric patients.